[1] Zepbound may delay gastric emptying, potentially reducing oral contraceptive effectiveness for 4 weeks after initiation or dose escalation, requiring backup contraception during these periods
They point to the pharmacokinetic rationale, the consistent anecdotal evidence from patients, and the low theoretical risk when total weekly dose is maintained
Worse, it could be misleading, sending your research down a dead-end path that costs valuable time and resources
Shared Nordic Trends Across Denmark, Sweden, and Norway: Endocrinologists (hormone doctors), obesity specialists, and private weight clinics play a significant role in prescribing GLP-1 medicines Doctors encourage using these medicines together with healthy lifestyle changes, not as the only solution There have been supply shortages, especially for Wegovy, as more people seek these treatments